Top 3 Health Care Stocks You’ll Regret Missing In May

by | May 26, 2026 | General

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

Universal Health Services Inc (NYSE:UHS)

  • On April 27, Universal Health Services reported better-than-expected first-quarter financial results. The company’s stock fell around 12% over the past month and has a 52-week low of $152.33.
  • RSI Value: 29.9
  • UHS Price Action: Shares of Universal Health fell 2.9% to close at $157.80 on Friday.
  • Edge Stock Ratings: 5.95 Momentum score with Value at 93.18.

Zoetis Inc (NYSE:ZTS)      

  • On May 22, Stifel analyst Jonathan Block maintained Zoetis with a Hold and lowered the price target from $105 to $95. The company’s stock fell around 31% over the past month and has a 52-week low of $72.38.
  • RSI Value: 28.8
  • ZTS Price Action: Shares of Zoetis rose 1.6% to close at $81.32 on Friday.
  • Benzinga Pro’s charting tool helped identify the trend in ZTS stock.

Vaxcyte Inc (NASDAQ:PCVX)

  • On May 6, Vaxcyte reported worse-than-expected first-quarter EPS results. “In the first quarter of 2026, we completed an equity financing that further strengthened our balance sheet and extended our cash runway,” said Andrew Guggenhime, President and Chief Financial Officer of Vaxcyte. “With $2.7 billion in cash, cash equivalents and investments as of March 31, 2026, we are well positioned to execute on our planned clinical, manufacturing and commercial readiness milestones for our PCV development programs and support the Company’s next phase of growth.” The company’s stock fell around 21% over the past month and has a 52-week low of $29.10.
  • RSI Value: 28.7
  • PCVX Price Action: Shares of Vaxcyte fell 0.2% to close at $47.30 on Friday.
  • Benzinga Pro’s signals feature notified of a potential breakout in PCVX shares.

Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and see how they compare.

Photo via Shutterstock